The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis
Authors
Keywords
-
Journal
Brain and Behavior
Volume 7, Issue 6, Pages e00696
Publisher
Wiley
Online
2017-05-09
DOI
10.1002/brb3.696
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects
- (2016) Xiao Hu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
- (2016) Joseph Menzin et al. JOURNAL OF MANAGED CARE PHARMACY
- Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study
- (2015) Xiao Hu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
- (2015) Maria Pia Amato et al. CNS DRUGS
- Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15
- (2015) Ludwig Kappos et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pregnancy outcomes in patients exposed to interferon beta-1b: Table 1
- (2014) Rebecca S Romero et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE
- (2014) Bernd C Kieseier et al. Multiple Sclerosis Journal
- A Novel PEGylated Interferon Beta-1a for Multiple Sclerosis: Safety, Pharmacology, and Biology
- (2011) Xiao Hu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- In Vivo Pharmacology and Toxicology Evaluation of Polyethylene Glycol-Conjugated Interferon -1a
- (2011) X. Hu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
- (2010) Antonio Scalfari et al. BRAIN
- Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis
- (2010) Stephanie C. Steinberg et al. CLINICAL DRUG INVESTIGATION
- The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
- (2010) V. Devonshire et al. EUROPEAN JOURNAL OF NEUROLOGY
- Real-life impact of early interferonβ therapy in relapsing multiple sclerosis
- (2009) M. Trojano et al. ANNALS OF NEUROLOGY
- Emerging PEGylated drugs
- (2009) Jung Seok Kang et al. EXPERT OPINION ON EMERGING DRUGS
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search